The durability of sitagliptin in elderly patients with type 2 diabetes

Código QR

The durability of sitagliptin in elderly patients with type 2 diabetes

Ching-Jung Hsieh, Feng-Chih Shen Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan Aim: To evaluate the durability of sitagli...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Hsieh CJ, Shen FC
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	Type 2 diabetes Sitagliptin Oral anti-diabetic drugs Dipeptidyl peptidase IV inhibitor Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/ac817c4695f84725b3ff6c9f1349316b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Clinical utility of fixed combinations of sitagliptin–metformin in treatment of type 2 diabetes
por: Green J, et al.
Publicado: (2010)

Use of DPP-4 inhibitors in type 2 diabetes: focus on sitagliptin
por: Ahren B
Publicado: (2010)

Tolerability and efficacy of glycemic control with saxagliptin in older patients (aged ≥ 65 years) with inadequately controlled type 2 diabetes mellitus
por: Karyekar CS, et al.
Publicado: (2013)

Randomized Study Comparing Vildagliptin vs Glibenclamide on Glucose Variability and Endothelial Function in Patients with Type 2 Diabetes Mellitus and Hypertension
por: Cosenso-Martin LN, et al.
Publicado: (2020)

The Effect of Bioactive Polyphenols from <i>Anacardium occidentale</i> Linn. Leaves on α-Amylase and Dipeptidyl Peptidase IV Activities
por: Nur Imanina Abdullah Thaidi, et al.
Publicado: (2020)

Gliptins vs. Milk-derived Dipeptidyl-Peptidase IV Inhibiting Biopeptides: Physicochemical Characterization and Pharmacokinetic Profiling
por: Jorge Andrés Barrero, et al.
Publicado: (2021)

Minimizing the risk of hypoglycemia in patients with type 2 diabetes mellitus
por: Kushner P
Publicado: (2010)

Saxagliptin for type 2 diabetes
por: Chacra
Publicado: (2010)

Mechanisms of cardiovascular protection of non-insulin antidiabetic medications
por: Angelo Avogaro
Publicado: (2018)

Predictors of the Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Taiwanese Patients with Type 2 Diabetes Mellitus
por: Lin YH, et al.
Publicado: (2019)

Possible applications of gliptins (dipeptidyl peptidase-4 inhibitors) in patients with type 2 diabetes mellitus on the various modes of insulin therapy
por: Gagik Radikovich Galstyan, et al.
Publicado: (2015)

Achieving glycemic control in elderly patients with type 2 diabetes: a critical comparison of current options
por: Du YF, et al.
Publicado: (2014)

Experience with sitagliptin (the first DPP-4 inhibitor) application to the treatment of type 2 diabetes mellitus in the Russian Federation:Results of the DIA-DA observation program
por: Marina Vladimirovna Shestakova
Publicado: (2010)

Dipeptidyl peptidase-4 inhibitors as add-on therapy to insulin in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
por: Wang N, et al.
Publicado: (2019)

Efficacy and safety of metformin-sitagliptin combination for the treatment of patients with diabetes mellitus and obesity
por: Alexander Sergeevich Ametov, et al.
Publicado: (2010)

Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus
por: Han E, et al.
Publicado: (2020)

Body mass index is associated with type 2 diabetes mellitus in Chinese elderly
por: Zhao Q, et al.
Publicado: (2017)

Comparative evaluation of empagliflozin, canagliflozin and sitagliptin cardioprotective properties in rats with experimental type 2 diabetes mellitus
por: A. V. Simanenkova, et al.
Publicado: (2021)

Type 2 diabetes mellitus in elderly patients treated with endocrinologists in clinical practice
por: Elena V. Biryukova
Publicado: (2019)

Importance of hypoglycemia on the risk of Alzheimer’s disease in elderly subjects with diabetes mellitus
por: Muratli S, et al.
Publicado: (2015)

Response to “Oral health in the elderly patient and its impact on general well-being: a nonsystematic review” paper
por: Muc-Wierzgoń M, et al.
Publicado: (2015)

Adjunctive therapy for glucose control in patients with type 1 diabetes
por: Harris K, et al.
Publicado: (2018)

Evaluation of EX-PRESS glaucoma implant in elderly diabetic patients after 23G vitrectomy
por: Lyssek-Boroń A, et al.
Publicado: (2017)

Heart-type fatty acid binding protein levels in elderly diabetics without known cardiovascular disease
por: Beysel S, et al.
Publicado: (2017)

Bisphosphonate therapy and osteonecrosis of the jaw complicated with a temporal abscess in an elderly woman with rheumatoid arthritis: a case report
por: Manzon L, et al.
Publicado: (2014)

Teneligliptin in management of type 2 diabetes mellitus
por: Sharma SK, et al.
Publicado: (2016)

Ulceration of the oral mucosa following direct contact with ferrous sulfate in elderly patients: a case report and a review of the French National Pharmacovigilance Database
por: Liabeuf S, et al.
Publicado: (2014)

The role of perioperative oral nutritional supplementation in elderly patients after hip surgery
por: Liu M, et al.
Publicado: (2015)

Predictors of improved functional outcome in elderly inpatients after rehabilitation: a retrospective study
por: Naruishi K, et al.
Publicado: (2014)

Age and recurrent stroke are related to the severity of white matter hyperintensities in lacunar infarction patients with diabetes
por: Yu L, et al.
Publicado: (2018)

Incretin-based therapy: renal effects
por: Anton Ivanovich Korbut, et al.
Publicado: (2016)

Zonisamide in the management of epilepsy in the elderly
por: Romigi A, et al.
Publicado: (2015)

Vildagliptin: the first innovative DDP-4 inhibitor
por: Edvin Villkhauer
Publicado: (2010)

Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer’s disease: a 6-month, randomized, placebo-controlled, multicenter trial
por: Wade AG, et al.
Publicado: (2014)

Depression influences the quality of diabetes-related self-management activities in elderly patients with type 2 diabetes: a cross-sectional study
por: Mut-Vitcu G, et al.
Publicado: (2016)

Association of Low Leptin with Poor 3-Month Prognosis in Ischemic Stroke Patients with Type 2 Diabetes
por: Zou Y, et al.
Publicado: (2020)

Age as an independent factor for the development of neuropathy in diabetic patients
por: Popescu S, et al.
Publicado: (2016)

Development, validation, and administration of a treatment-satisfaction questionnaire for caregivers of dependent type 2 diabetic patients
por: García-Aparicio J, et al.
Publicado: (2015)

Oral health status, dental treatment needs, and barriers to dental care of elderly care home residents in Lodz, Poland
por: Gaszynska E, et al.
Publicado: (2014)

Identification of the drug-use behaviors of the elderly living in nursing homes
por: Oguzoncul AF, et al.
Publicado: (2018)